CD163 and non-small cell lung carcinoma: The high number of macrophages (CD163+ macrophages, non-classical monocytes, and intermediate monocytes) in LUAD is consistent with early findings indicating their crucial protumorigenic role in non-small cell lung cancer (NSCLC) niche [13, 24].